author_facet Xue, Chu-Biao
Feng, Hao
Cao, Ganfeng
Huang, Taisheng
Glenn, Joseph
Anand, Rajan
Meloni, David
Zhang, Ke
Kong, Lingquan
Wang, Anlai
Zhang, Yingxin
Zheng, Changsheng
Xia, Michael
Chen, Lihua
Tanaka, Hiroyuki
Han, Qi
Robinson, D. J.
Modi, Dilip
Storace, Lou
Shao, Lixin
Sharief, Vaqar
Li, Mei
Galya, Laurine G.
Covington, Maryanne
Scherle, Peggy
Diamond, Sharon
Emm, Tom
Yeleswaram, Swamy
Contel, Nancy
Vaddi, Kris
Newton, Robert
Hollis, Greg
Friedman, Steven
Metcalf, Brian
Xue, Chu-Biao
Feng, Hao
Cao, Ganfeng
Huang, Taisheng
Glenn, Joseph
Anand, Rajan
Meloni, David
Zhang, Ke
Kong, Lingquan
Wang, Anlai
Zhang, Yingxin
Zheng, Changsheng
Xia, Michael
Chen, Lihua
Tanaka, Hiroyuki
Han, Qi
Robinson, D. J.
Modi, Dilip
Storace, Lou
Shao, Lixin
Sharief, Vaqar
Li, Mei
Galya, Laurine G.
Covington, Maryanne
Scherle, Peggy
Diamond, Sharon
Emm, Tom
Yeleswaram, Swamy
Contel, Nancy
Vaddi, Kris
Newton, Robert
Hollis, Greg
Friedman, Steven
Metcalf, Brian
author Xue, Chu-Biao
Feng, Hao
Cao, Ganfeng
Huang, Taisheng
Glenn, Joseph
Anand, Rajan
Meloni, David
Zhang, Ke
Kong, Lingquan
Wang, Anlai
Zhang, Yingxin
Zheng, Changsheng
Xia, Michael
Chen, Lihua
Tanaka, Hiroyuki
Han, Qi
Robinson, D. J.
Modi, Dilip
Storace, Lou
Shao, Lixin
Sharief, Vaqar
Li, Mei
Galya, Laurine G.
Covington, Maryanne
Scherle, Peggy
Diamond, Sharon
Emm, Tom
Yeleswaram, Swamy
Contel, Nancy
Vaddi, Kris
Newton, Robert
Hollis, Greg
Friedman, Steven
Metcalf, Brian
spellingShingle Xue, Chu-Biao
Feng, Hao
Cao, Ganfeng
Huang, Taisheng
Glenn, Joseph
Anand, Rajan
Meloni, David
Zhang, Ke
Kong, Lingquan
Wang, Anlai
Zhang, Yingxin
Zheng, Changsheng
Xia, Michael
Chen, Lihua
Tanaka, Hiroyuki
Han, Qi
Robinson, D. J.
Modi, Dilip
Storace, Lou
Shao, Lixin
Sharief, Vaqar
Li, Mei
Galya, Laurine G.
Covington, Maryanne
Scherle, Peggy
Diamond, Sharon
Emm, Tom
Yeleswaram, Swamy
Contel, Nancy
Vaddi, Kris
Newton, Robert
Hollis, Greg
Friedman, Steven
Metcalf, Brian
ACS Medicinal Chemistry Letters
Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist
Organic Chemistry
Drug Discovery
Biochemistry
author_sort xue, chu-biao
spelling Xue, Chu-Biao Feng, Hao Cao, Ganfeng Huang, Taisheng Glenn, Joseph Anand, Rajan Meloni, David Zhang, Ke Kong, Lingquan Wang, Anlai Zhang, Yingxin Zheng, Changsheng Xia, Michael Chen, Lihua Tanaka, Hiroyuki Han, Qi Robinson, D. J. Modi, Dilip Storace, Lou Shao, Lixin Sharief, Vaqar Li, Mei Galya, Laurine G. Covington, Maryanne Scherle, Peggy Diamond, Sharon Emm, Tom Yeleswaram, Swamy Contel, Nancy Vaddi, Kris Newton, Robert Hollis, Greg Friedman, Steven Metcalf, Brian 1948-5875 1948-5875 American Chemical Society (ACS) Organic Chemistry Drug Discovery Biochemistry http://dx.doi.org/10.1021/ml200030q Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist ACS Medicinal Chemistry Letters
doi_str_mv 10.1021/ml200030q
facet_avail Online
Free
finc_class_facet Chemie und Pharmazie
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAyMS9tbDIwMDAzMHE
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAyMS9tbDIwMDAzMHE
institution DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Zi4
DE-Gla1
DE-15
DE-Pl11
DE-Rs1
DE-14
DE-105
DE-Ch1
DE-L229
imprint American Chemical Society (ACS), 2011
imprint_str_mv American Chemical Society (ACS), 2011
issn 1948-5875
issn_str_mv 1948-5875
language English
mega_collection American Chemical Society (ACS) (CrossRef)
match_str xue2011discoveryofincb3284apotentselectiveandorallybioavailablehccr2antagonist
publishDateSort 2011
publisher American Chemical Society (ACS)
recordtype ai
record_format ai
series ACS Medicinal Chemistry Letters
source_id 49
title Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist
title_unstemmed Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist
title_full Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist
title_fullStr Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist
title_full_unstemmed Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist
title_short Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist
title_sort discovery of incb3284, a potent, selective, and orally bioavailable hccr2 antagonist
topic Organic Chemistry
Drug Discovery
Biochemistry
url http://dx.doi.org/10.1021/ml200030q
publishDate 2011
physical 450-454
description
container_issue 6
container_start_page 450
container_title ACS Medicinal Chemistry Letters
container_volume 2
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792343106900721677
geogr_code not assigned
last_indexed 2024-03-01T16:46:24.671Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Discovery+of+INCB3284%2C+a+Potent%2C+Selective%2C+and+Orally+Bioavailable+hCCR2+Antagonist&rft.date=2011-06-09&genre=article&issn=1948-5875&volume=2&issue=6&spage=450&epage=454&pages=450-454&jtitle=ACS+Medicinal+Chemistry+Letters&atitle=Discovery+of+INCB3284%2C+a+Potent%2C+Selective%2C+and+Orally+Bioavailable+hCCR2+Antagonist&aulast=Metcalf&aufirst=Brian&rft_id=info%3Adoi%2F10.1021%2Fml200030q&rft.language%5B0%5D=eng
SOLR
_version_ 1792343106900721677
author Xue, Chu-Biao, Feng, Hao, Cao, Ganfeng, Huang, Taisheng, Glenn, Joseph, Anand, Rajan, Meloni, David, Zhang, Ke, Kong, Lingquan, Wang, Anlai, Zhang, Yingxin, Zheng, Changsheng, Xia, Michael, Chen, Lihua, Tanaka, Hiroyuki, Han, Qi, Robinson, D. J., Modi, Dilip, Storace, Lou, Shao, Lixin, Sharief, Vaqar, Li, Mei, Galya, Laurine G., Covington, Maryanne, Scherle, Peggy, Diamond, Sharon, Emm, Tom, Yeleswaram, Swamy, Contel, Nancy, Vaddi, Kris, Newton, Robert, Hollis, Greg, Friedman, Steven, Metcalf, Brian
author_facet Xue, Chu-Biao, Feng, Hao, Cao, Ganfeng, Huang, Taisheng, Glenn, Joseph, Anand, Rajan, Meloni, David, Zhang, Ke, Kong, Lingquan, Wang, Anlai, Zhang, Yingxin, Zheng, Changsheng, Xia, Michael, Chen, Lihua, Tanaka, Hiroyuki, Han, Qi, Robinson, D. J., Modi, Dilip, Storace, Lou, Shao, Lixin, Sharief, Vaqar, Li, Mei, Galya, Laurine G., Covington, Maryanne, Scherle, Peggy, Diamond, Sharon, Emm, Tom, Yeleswaram, Swamy, Contel, Nancy, Vaddi, Kris, Newton, Robert, Hollis, Greg, Friedman, Steven, Metcalf, Brian, Xue, Chu-Biao, Feng, Hao, Cao, Ganfeng, Huang, Taisheng, Glenn, Joseph, Anand, Rajan, Meloni, David, Zhang, Ke, Kong, Lingquan, Wang, Anlai, Zhang, Yingxin, Zheng, Changsheng, Xia, Michael, Chen, Lihua, Tanaka, Hiroyuki, Han, Qi, Robinson, D. J., Modi, Dilip, Storace, Lou, Shao, Lixin, Sharief, Vaqar, Li, Mei, Galya, Laurine G., Covington, Maryanne, Scherle, Peggy, Diamond, Sharon, Emm, Tom, Yeleswaram, Swamy, Contel, Nancy, Vaddi, Kris, Newton, Robert, Hollis, Greg, Friedman, Steven, Metcalf, Brian
author_sort xue, chu-biao
container_issue 6
container_start_page 450
container_title ACS Medicinal Chemistry Letters
container_volume 2
description
doi_str_mv 10.1021/ml200030q
facet_avail Online, Free
finc_class_facet Chemie und Pharmazie
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAyMS9tbDIwMDAzMHE
imprint American Chemical Society (ACS), 2011
imprint_str_mv American Chemical Society (ACS), 2011
institution DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Zi4, DE-Gla1, DE-15, DE-Pl11, DE-Rs1, DE-14, DE-105, DE-Ch1, DE-L229
issn 1948-5875
issn_str_mv 1948-5875
language English
last_indexed 2024-03-01T16:46:24.671Z
match_str xue2011discoveryofincb3284apotentselectiveandorallybioavailablehccr2antagonist
mega_collection American Chemical Society (ACS) (CrossRef)
physical 450-454
publishDate 2011
publishDateSort 2011
publisher American Chemical Society (ACS)
record_format ai
recordtype ai
series ACS Medicinal Chemistry Letters
source_id 49
spelling Xue, Chu-Biao Feng, Hao Cao, Ganfeng Huang, Taisheng Glenn, Joseph Anand, Rajan Meloni, David Zhang, Ke Kong, Lingquan Wang, Anlai Zhang, Yingxin Zheng, Changsheng Xia, Michael Chen, Lihua Tanaka, Hiroyuki Han, Qi Robinson, D. J. Modi, Dilip Storace, Lou Shao, Lixin Sharief, Vaqar Li, Mei Galya, Laurine G. Covington, Maryanne Scherle, Peggy Diamond, Sharon Emm, Tom Yeleswaram, Swamy Contel, Nancy Vaddi, Kris Newton, Robert Hollis, Greg Friedman, Steven Metcalf, Brian 1948-5875 1948-5875 American Chemical Society (ACS) Organic Chemistry Drug Discovery Biochemistry http://dx.doi.org/10.1021/ml200030q Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist ACS Medicinal Chemistry Letters
spellingShingle Xue, Chu-Biao, Feng, Hao, Cao, Ganfeng, Huang, Taisheng, Glenn, Joseph, Anand, Rajan, Meloni, David, Zhang, Ke, Kong, Lingquan, Wang, Anlai, Zhang, Yingxin, Zheng, Changsheng, Xia, Michael, Chen, Lihua, Tanaka, Hiroyuki, Han, Qi, Robinson, D. J., Modi, Dilip, Storace, Lou, Shao, Lixin, Sharief, Vaqar, Li, Mei, Galya, Laurine G., Covington, Maryanne, Scherle, Peggy, Diamond, Sharon, Emm, Tom, Yeleswaram, Swamy, Contel, Nancy, Vaddi, Kris, Newton, Robert, Hollis, Greg, Friedman, Steven, Metcalf, Brian, ACS Medicinal Chemistry Letters, Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist, Organic Chemistry, Drug Discovery, Biochemistry
title Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist
title_full Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist
title_fullStr Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist
title_full_unstemmed Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist
title_short Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist
title_sort discovery of incb3284, a potent, selective, and orally bioavailable hccr2 antagonist
title_unstemmed Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist
topic Organic Chemistry, Drug Discovery, Biochemistry
url http://dx.doi.org/10.1021/ml200030q